Lexington Biosciences, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced net loss was CAD 126,858 compared to CAD 781,567 a year ago. Basic earnings per share from continuing operations was CAD 0.05 compared to CAD 0.21 a year ago. For the half year, net loss was CAD 330,326 compared to CAD 1.525 million a year ago. Basic earnings per share from continuing operations was CAD 0.09 compared to CAD 0.4 a year ago.